Buy these top quality ASX 200 shares for your self-managed superannuation fund

Analysts think these are top buys for super investors right now.

| More on:
Couple holding a piggy bank, symbolising superannuation.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking for some ASX 200 shares for your self-managed superannuation fund (SMSF) this month?

If you are, it could be worth checking out the quality companies named below. They have all been tipped as buys with attractive upside. Here's what you need to know about them:

CSL Limited (ASX: CSL)

CSL could be a great option for a SMSF. It is one of the world's leading biotechnology companies that has been around for over a century, starting life as the Commonwealth Serum Laboratories.

It has stayed true to its roots since then with its key CSL Behring plasma business, whilst also expanding into other areas through its CSL Seqirus vaccines business and the CSL Vifor renal therapies business.

But CSL won't be stopping there. Each year it reinvests 10% to 12% of its sales back into research and development (R&D) activities. This ensures that it stays at the forefront of the industry and has a pipeline of potentially lucrative products to underpin its long term growth.

Analysts at Citi are positive on the company. They currently have a buy rating and $335.00 price target on its shares. Based on the current CSL share price, this implies potential upside of 10%.

Goodman Group (ASX: GMG)

Another ASX 200 share for SMSF investors to consider is Goodman Group. It is a leading integrated commercial and industrial property company.

It has been among the best performers on the Australian share market over the past decade. This has been driven by the insatiable demand for industrial property and management's strategy of developing high-quality properties in strategic locations.

Goodman appears well-placed to continue this positive form for the foreseeable future. This is thanks to its huge development pipeline, which includes data centres that are in demand due to the artificial intelligence megatrend.

Citi is also bullish on Goodman and has a buy rating and $40.00 price target on its shares. Based on its current share price of $34.58, this implies potential upside of almost 16%.

ResMed Inc. (ASX: RMD)

A third ASX 200 share to look at for your SMSF could be ResMed. It is a leading medical device company with a focus on the sleep disorder market.

This is a huge market to operate in. For example, last week its CEO, Mick Farrell stated that "nearly 2.5 billion suffer from major sleep health and breathing disorders."

And "as the market leader in these significantly underpenetrated markets, we're well-positioned as the clear leader to drive increased market penetration, demand generation, and accelerate growth for our businesses," Farrell added.

It's no wonder then that a number of brokers are bullish on ResMed. One of those is Macquarie, which has an outperform rating and $35.40 price target on its shares. This suggests that upside of over 11% is possible from current levels.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in CSL and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goodman Group, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended CSL and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A young woman sits on a sofa in a stylish home with her laptop computer balanced on her knee and smiles with a satisfied look on her face at what she's seeing on the screen.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These stocks could provide strong passive income.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Blue Chip Shares

3 ASX 200 blue chip shares to buy with $3,000 in July

Analysts have recently named these well-known stocks as top buys.

Read more »

Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet
Blue Chip Shares

3 fantastic ASX shares to buy for an SMSF

Let's see why these shares that brokers rate as buys could be top picks for super investors.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Blue Chip Shares

Buy these fantastic ASX 200 blue chips with $10,000

Analysts think these top stocks are buys right now.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Blue Chip Shares

The best ASX shares to buy and forget for 10+ years

Want to make long term investments? Here are three picks that brokers rate as buys.

Read more »

An ASX investor in a business shirt and tie looks at his computer screen and scratches his head with one hand wondering if he should buy ASX shares yet
Blue Chip Shares

This popular ASX 200 blue-chip share has literally gone nowhere in 17 years

Even blue-chip shares can fall short.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Blue Chip Shares

3 no-brainer ASX shares to buy now with $5,000

Brokers think these shares could be among the best to buy right now.

Read more »

Broker checking out the share price oh his smartphone and laptop.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These businesses are predicted to pay significant passive income to shareholders.

Read more »